Drugs / Epidiferphane
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05074290 | Mar 2023 → Dec 2026 expected | breast cancer | University of Florida | Recruiting | No outcome recorded |
| Phase 1/2 | NCT03611985 | Mar 2020 → Mar 2023 | breast cancer | University of Florida | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Epidiferphane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05074290 ↗ |
| Route | Oral | “tablets orally” NCT03611985 ↗ |